Woman and Man
- | Country :
- Thailand
- | organs : -
- | Specialty : -
Extract
This is an open, randomized, multicenter clinical trial. Objectives: - To describe the safety profiles during the 21 days following each primary and booster injection. - To describe the immune response 21 days after each primary and booster injection of each formulation. - To describe the antibody persistence after the first vaccination
Inclusion criteria
- Influenza ,Orthomyxoviridae Infections ,Influenza A Virus Infection